[ Price : $8.95]
Eli Lilly says a head-to-head clinical trial comparing its migraine drug Emgality (galcanezumab-gnlm) to Pfizers Nurtec ODT (Rimeg...[ Price : $8.95]
FDA approves Premia Spines TOPS System as an alternative to spinal fusion for treating certain patients with degenerative spondylo...[ Price : $8.95]
FDA publishes a CVM guidance entitled #171 Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Me...[ Price : $8.95]
FDA grants Genentech accelerated approval for its BLA for Columvi (glofitamab-gxbm) and its use in treating adult patients with re...[ Price : $8.95]
FDA approves a Bristol Myers Squibb supplemental NDA to add positive data from its Phase 3 VALOR-HCM study to the U.S. prescribing...[ Price : $8.95]
FDA advises manufacturers that they should develop vaccines with a monovalent XBB.1.5 composition, according to a notice posted on...[ Price : $8.95]
Reps. Schiff and Kuster introduce legislation to direct FDA to establish a process to allow generic drug manufacturers to update d...[ Price : $8.95]
FDAs Vaccines and Related Biological Products Advisory Committee votes 21 to 0 that the Covid-19 vaccination program for the 2023-...